Platinum–etoposide chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Platinum–etoposide chemotherapy, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer [Phase 2]